BACKGROUND: Systemic lupus erythematosus (SLE) or Lupus is one of the leading causes of work disability in the United States, accounting for about 20% of the more than estimated 1.5 million Americans with a work disability. The symptoms of lupus can have a profound impact on the person’s employment. Impacts of lupus are more pronounced among young and middle-adulthood. Studies have shown that loss in work hours cost the nation nearly $13 billion annually. The loss also impacts the individual’s work, quality of life, self-management, and self-efficacy.
OBJECTIVE: In this article, the author describes the financial burden of lupus. The article also describes the substantial impact of lupus on employment outcomes for individuals living with the condition. The author also reviews major signs and symptoms of disease and their impact on employment.
RESULTS: Findings from this research can be used to identify various accommodations and strategies for individuals to prevent flare-ups.
CONCLUSIONS: The paper presents innovative strategies that include early interventions and how employers andco-workers can provide helpful support that includes job accommodations to individuals with lupus.
PartridgeAJ, KarlsonEW, DaltroyLH, LewRA, WrightEA, FosselAH, et al. Risk factors for early work disability in systemic lupus erythematosus: Results from a multicenter study. Arthritis Rheum1997;40(12):2199–206.
2.
PackTG, SzironyGM, KushnerJD, BellawJR. Quality of life and employment in persons with multiple sclerosis. Work J Prev Assess Rehabil2014;49(2):281–7.
AbbottJ, GrayJ, WilliamsA, TehL-S. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: A qualitative study. Lupus2010;19(14):1640–7.
5.
MosesN, WiggersJ, NicholasC, CockburnJ. Prevalence and correlates of perceived unmet needs of people with systemic lupus erythematosus. Patient Educ Couns2005;57(1):30–8.
6.
WallaceD. The Lupus Book. 2000. Oxford Univ PressNew York.
7.
ScofieldL, ReinlibL, AlarcónGS, CooperGS. Employment and disability issues in systemic lupus erythematosus: A review. Arthritis Rheum2008;59(10):1475–9.
8.
FalvoDR. Medical and psychosocial aspects of chronic illness and disability. Rehabilitation Psychology2005;572.
9.
GarrisC, OglesbyA, SulcsE, LeeM. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States. Lupus2013;22:1077–86.
10.
Understanding Lupus [Internet]. Lupus Foundation of America. 2013. Available from: http://www.lupus.org
BakerK, PopeJ. Employment and work disability in systemic lupus erythematosus: A systematic review. Rheumatology (Oxford)2009;48(3):281–4.
13.
GordonC, IsenbergD, LerstromK, NortonY, Nika”iE, PushparajahD, et al. The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: A European patient-driven online survey. Rheumatology2013;52(12):2292–301.
14.
BonguA, ChangE, Ramsey-GoldmanR. Can morbidity and mortality of SLE be improved?Best Pract Res Clin Rheumatol2002;16(2):313–32.
BeckermanNL, SarraccoM. Listening to lupus patients and families: Fine tuning the assessment. Soc Work Health Care2012;51(7):597–612.
17.
ClowseMEB. Dubois’ Lupus Erythematosus and Related Syndromes. Dubois’ Lupus Erythematosus and Related Syndromes2013;455–63.
18.
McElhoneK, AbbottJ, TehLS. A review of health related quality of life in systemic lupus erythematosus. Lupus2006;15(10):633–43.
19.
YelinE, TrupinL, KatzP, CriswellL, YazdanyJ, GillisJ, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum2007;57(1):56–63.
20.
IppolitoA, PetriM. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol2008;26(5 Suppl 51):S72–9.
21.
UrowitzMB, GladmanDD, Abu-ShakraM, FarewellVT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol1997;24(6):1061–5.
22.
AbererE. Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus. Lupus2010;19(9):1118–24.
23.
AllaireSJ, AlHereshR, KeysorJJ. Risk factors for work disability associated with arthritis and other rheumatic conditions. Work2013;45(4):499–503.
24.
SchneiderM. The Substantial Negative Impact of Systemic Lupus Erythematosus on the Working Lives of Patients: Results of the Lupus European Online Survey. Arthritis Rheum2011.
25.
AllaireSJ, KeysorJJ, AlHereshR. Effect of arthritis and other rheumatic conditions on employment. Work2013;45(3):417–20.
26.
MacejováZ, ZárikováM, OetterováM. Systemic lupus erythematosus– disease impact on patients. Cent Eur J Public Health2013;21(3):171–3.
27.
SlawskyKA, FernandesAW, FusfeldL, ManziS, GossTF. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care Res2011;63(9):1224–32.
28.
ZhuTY, TamL-S, LeeVW-Y, LeeKK-C, LiEK. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum2009;61(9):1159–67.
29.
PanopalisP, YazdanyJ, GillisJZ, JulianL, TrupinL, HershAO, et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum2008;59(12):1788–95.
30.
PanopalisP, PetriM, ManziS, IsenbergDA, GordonC, SenécalJ-L, et al. The systemic lupus erythematosus Tri-Nation study: Cumulative indirect costs. Arthritis Rheum2007;57(1):64–70.
31.
AgarwalN, BarnesEF, KumarV. Treatment planning for individuals with lupus: Case conceptualization using the DOACLIENTMAP framework. J Appl Rehabil Couns. NRCA2015;46(1):14–24.
32.
McElhoneK, AbbottJ, GrayJ, WilliamsA, TehL. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts. a qualitative study. Lupus2010.
33.
BeckermanNL. Living with lupus: A qualitative report. Soc Work Health Care2011;330–43.
34.
TenchCM, McCurdieI, WhitePD, D’CruzDP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford)2000;39(11):1249–54.
35.
CleanthousS, TyagiM, IsenbergDA, NewmanSP. What do we know about self-reported fatigue in systemic lupus erythematosus?Lupus2012;21(5):465–76.
36.
PanopalisP, JulianL, YazdanyJ, GillisJZ, TrupinL, HershA, et al. Impact of Memory Impairment on Employment Status in Persons With Systemic Lupus Erythematosus. Arthritis Rheum2007;57(8):1453–60.
37.
HollowayL, HumphreyL, HeronL, PillingC, KitchenH, HøjbjerreL, et al. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: A review of content validity, face validity and psychometric performance. Health Qual Life Outcomes2014;12:116.
38.
AgarwalN, YasuiY, KumarV. Lupus: Vocational Aspects and the Best Rehabilitation Practices. J Vocat Rehabil2015;43:83–90.
39.
JollyM, PickardAS, WilkeC, MikolaitisRA, TehL-S, McElhoneK, et al. Lupus-specific health outcome measure for US patients: The LupusQoL-US version. Ann Rheum Dis2010;69(1):29–33.
40.
GallopK, NixonA, SwinburnP, SterlingKL, NaegeliAN, SilkM, et al. Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient’s perspective. Lupus2012;21(9):934–43.
41.
BijlM, KallenbergCG. Ultraviolet light and cutaneous lupus. Lupus2006;724–7.
42.
CaricchioR, McPhieL, CohenPL. Ultraviolet B radiation-induced cell death: Critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol2003;171(11):5778–86.
43.
ElbirtD, SthoegerD, AsherI, SthoegerZM. The management of systemic lupus erythematosus: Facts and controversies. Clin Dermatol2010;28(3):330–6.
44.
MalviyaA, WilsonG, KleimB, KurtzSM, DeehanD. Factors influencing return to work after hip and knee replacement. Occup Med (Lond) [Internet]. 2014 Sep 1 [cited 2016 Jan 6];64(6):402-9. Available from: http://occmed.oxfordjournals.org/content/64/6/402.short
45.
KozoraE, HanlyJG, LaptevaLFC. Cognitive dysfunction in systemic lupus erythematosus: Past, present, and future. Arthritis Rheum2008;58(11):3286–3298.
46.
HarrisonMJ, MorrisKA, HortonR, TogliaJ, BarskyJ, ChaitS, et al. Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology2005;65(8):1325–7.
47.
YelinE, HenkeC, EpsteinW. The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum1987;30(5):507–12.
48.
PooleJL, AtanasoffG, PelsorJC, SibbittWL, BrooksWM. Relationships between person and health factors and job characteristics in women with systemic lupus erythematosus. Work2007;28(1):95–100.
49.
VickA, LightmanE. Barriers to Employment Among Women With Complex Episodic Disabilities. J Disabil Policy Stud2010;21(2):70–80.
50.
US Department of Justice. The Americans with Disabilities Act of and Revised ADA Regulations Implementing Title II and Title III. Laws/Regulations [Internet]. 2014;1990(c):1-51. Available from: http://www.ada.gov/2010_regs.htm
51.
KesslerRC, GreenbergPE, MickelsonKD, MeneadesLM, WangPS. The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med2001;43(3):218–25.
52.
AllaireSH. Update on work disability in rheumatic diseases. Curr Opin Rheumatol2001;13(2):93–8.
53.
YelinEH, HenkeCJ, EpsteinWV. Work disability among persons with musculoskeletal conditions. Arthritis Rheum [Internet]. 1986 Nov [cited 2016 Jan 6];29(11):1322-33. Available from: http://doi.wiley.com/10.1002/art.1780291104
